Every open market buy and sale of Nuvation Bio Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $118K bought and $7.6M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when NUVB insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an NUVB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every NUVB insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Gary HattersleyChief Scientific Officer | Sale plan | 100,000 | $7.09 | $709K | 0 | Aug 21Form 4 |
| Jun 23, 2026 | Kerry WentworthChief Regulatory Officer | Sale plan | 63,000 | $6.02 | $379K | 53,000 | Jun 24Form 4 |
| Jun 23, 2026 | Stacy MarkelChief People Officer | Sale plan | 125,000 | $6.03 | $753K | 32,591 | Jun 24Form 4 |
| Jun 23, 2026 | Philippe SauvageCFO | Sale plan | 47,668 | $6.01 | $286K | 12,673 | Jun 24Form 4 |
| Jun 9, 2026 | Robert MashalDirector | Buy | 25,000 | $4.73 | $118K | 225,000 | Jun 11Form 4 |
| Apr 17, 2026 | Kerry WentworthChief Regulatory Officer | Sale plan | 36,750 | $5.01 | $184K | 53,000 | Apr 21Form 4 |
| Apr 17, 2026 | Dongfang LiuChief Medical Officer | Sale plan | 50,000 | $5.02 | $251K | 18,000 | Apr 21Form 4 |
| Apr 6, 2026 | Kerry WentworthChief Regulatory Officer | Sale plan | 200,000 | $4.52 | $904K | 53,000 | Apr 8Form 4 |
| Dec 1, 2025 | Dongfang LiuChief Medical Officer | Sale | 150,000 | $7.82 | $1.2M | 18,000 | Dec 3Form 4 |
| Nov 26, 2025 | Dongfang LiuChief Medical Officer | Sale | 20,000 | $7.75 | $155K | 18,000 | Nov 26Form 4 |
| Nov 20, 2025 | Gary HattersleyChief Scientific Officer | Sale | 369,051 | $7.23 | $2.7M | 0 | Nov 24Form 4 |
| Nov 20, 2025 | Dongfang LiuChief Medical Officer | Sale | 20,000 | $7.00 | $140K | 18,000 | Nov 24Form 4 |
| Nov 19, 2025 | David C. HanleyChief Technical Operations | Sale | 200,000 | $7.14 | $1.4M | 24,000 | Nov 21Form 4 |
| Nov 19, 2025 | Dongfang LiuChief Medical Officer | Sale | 30,000 | $4.93 | $148K | 18,000 | Nov 19Form 4 |
| Oct 27, 2025 | Gary HattersleyChief Scientific Officer | Sale plan | 100,000 | $5.02 | $502K | 0 | Oct 29Form 4 |
NUVB insider trading FAQ
Are NUVB insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $118K of NUVB on the open market in 1 trades, and 5 sold $7.6M in 11 trades, 46% of that under pre-arranged trading plans.
When did an NUVB insider last buy shares?
Robert Mashal (Director) bought 25,000 shares for $118K on Jun 9, 2026, reported on Jun 11, 2026.
When did an NUVB insider last sell shares?
Gary Hattersley (Chief Scientific Officer) sold 100,000 shares for $709K on Aug 19, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
